CAR- T and cell genetics therapies are too expensive

.Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing as well as technology transmission may deliver cellular genetics therapies at a cost effective expense to clients around the globe.